GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 80 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $111,000 | -75.1% | 4,637 | -84.8% | 0.00% | – |
| Q4 2020 | $445,000 | +8800.0% | 30,507 | +8742.6% | 0.00% | – |
| Q3 2020 | $5,000 | -28.6% | 345 | -24.8% | 0.00% | – |
| Q2 2020 | $7,000 | +600.0% | 459 | +57.2% | 0.00% | – |
| Q1 2020 | $1,000 | -87.5% | 292 | -82.9% | 0.00% | – |
| Q4 2019 | $8,000 | – | 1,710 | +42650.0% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 4 | -98.9% | 0.00% | – |
| Q2 2019 | $2,000 | – | 377 | +9325.0% | 0.00% | – |
| Q1 2019 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 4 | -99.6% | 0.00% | – |
| Q3 2018 | $8,000 | – | 1,041 | +1606.6% | 0.00% | – |
| Q2 2018 | $0 | – | 61 | +1425.0% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 4 | -98.9% | 0.00% | – |
| Q4 2017 | $2,000 | -95.1% | 375 | -91.2% | 0.00% | – |
| Q3 2017 | $41,000 | +4000.0% | 4,283 | +3439.7% | 0.00% | – |
| Q2 2017 | $1,000 | -94.7% | 121 | -91.9% | 0.00% | – |
| Q1 2017 | $19,000 | -61.2% | 1,485 | -62.4% | 0.00% | – |
| Q4 2016 | $49,000 | +206.2% | 3,952 | +189.7% | 0.00% | – |
| Q3 2016 | $16,000 | +33.3% | 1,364 | +0.6% | 0.00% | – |
| Q2 2016 | $12,000 | +71.4% | 1,356 | +6.3% | 0.00% | – |
| Q1 2016 | $7,000 | -36.4% | 1,276 | -6.7% | 0.00% | – |
| Q4 2015 | $11,000 | -54.2% | 1,367 | -55.1% | 0.00% | – |
| Q3 2015 | $24,000 | -29.4% | 3,047 | -16.7% | 0.00% | – |
| Q2 2015 | $34,000 | +100.0% | 3,659 | +186.8% | 0.00% | – |
| Q1 2015 | $17,000 | 0.0% | 1,276 | 0.0% | 0.00% | – |
| Q4 2014 | $17,000 | – | 1,276 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|